Table 2.

Outcomes comparison among different exposure groups for all neonates (A) and neonates with GA < 26 weeks (B)

(A) All neonates
	Mg7D (N = 210)	No-Mg7D (N= 92)	P Value	Mg3D (N = 179)	No-Mg7D + No-Mg3D (N =123)	P Value	Mg3D (N = 179)	No-Mg3D (N = 31)	P Value
SIP	20 (9.5)	8 (8.7)	0.82	18 (10.1)	10 (8.1)	0.57	18 (10.1)	2 (6.4)	0.53
Early SIP	19 (9.1)	7 (7.6)	0.68	17 (9.5)	9 (7.3)	0.54	17 (9.5)	2 (6.5)	0.75
NEC	15 (7.1)	7 (7.6)	0.89	13 (7.3)	9 (7.3)	0.98	13 (7.3)	2 (6.5)	0.87
Early NEC	4 (1.9)	1 (1.1)	0.61	3 (1.7)	2 (1.6)	0.97	3 (1.7)	1 (3.2)	0.56
Death	24 (11.4)	12(13)	0.69	18 (10.1)	18 (14.6)	0.23	18 (10.1)	6 (19.4)	0.13
Early Death	15 (7.1)	10 (10.9)	0.28	13 (7.3)	12 (9.8)	0.44	13 (7.3)	2 (6.5)	0.87
SIP/NEC/Death	52 (24.8)	24 (26.1)	0.81	43 (24)	33 (26.8)	0.58	43 (24)	9 (29)	0.55
Early SIP/NEC/Death	34 (16.2)	16 (17.4)	0.79	29 (16.2)	21(17.1)	0.8412	29 (16.2)	5 (16.1)	0.99
(B) Neonates with GA < 26 weeks
	Mg7D (N = 90)	No-Mg7D (N= 45)	P Value	Mg3D (N = 75)	No-Mg7D + No-Mg3D (N = 60)	P Value	Mg3D (N = 75)	No-Mg3D (N = 15)	P Value
SIP	14 (15.6)	6 (13.3)	0.73	13 (17.3)	7 (11.7)	0.36	13 (17.3)	1 (6.7)	0.3
Early SIP	13 (14.4)	5(11.1)	0.79	12 (16)	6 (10)	0.44	12 (16)	1 (6.7)	0.69
NEC	8 (8.9)	6 (13.3)	0.42	6 (8)	8 (13)	0.31	6 (8)	2(13.3)	0.51
Early NEC	4 (4.4)	1 (2.2)	0.52	3 (4)	2 (3.3)	0.84	3 (4)	1 (6.7)	0.65
Death	18 (20)	10 (22.2)	0.76	13 (17.3)	15(25)	0.27	13 (17.3)	5 (33.3)	0.16
Early Death	12 (13.3)	9 (20)	0.31	10 (13.3)	11 (18.3)	0.43	10 (13.3)	2(13.3)	1.0
SIP/NEC/Death	34 (37.8)	20 (44.4)	0.46	27 (36)	27 (45)	0.29	27 (36)	7 (46.7)	0.44
Early SIP/NEC/Death	26 (28.9)	13 (28.9)	1.0	22 (29.3)	17 (28.3)	0.9	22 (29.3)	4 (26.7)	0.83

Data are number of neonates with a presenting variable, and values in parentheses are percent of each group.